Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 7,620 shares, a drop of 66.5% from the July 15th total of 22,725 shares. Based on an average daily trading volume, of 8,615 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.7% of the shares of the company are sold short.
Institutional Investors Weigh In On Global X HealthTech ETF
Several large investors have recently added to or reduced their stakes in the company. Glenmede Investment Management LP purchased a new stake in Global X HealthTech ETF during the third quarter valued at about $31,000. Banque Cantonale Vaudoise purchased a new position in shares of Global X HealthTech ETF in the third quarter worth about $37,000. EverSource Wealth Advisors LLC raised its position in shares of Global X HealthTech ETF by 26,522.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after purchasing an additional 2,387 shares during the period. Royal Bank of Canada raised its position in shares of Global X HealthTech ETF by 39.4% in the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock valued at $62,000 after purchasing an additional 736 shares during the period. Finally, Farther Finance Advisors LLC bought a new stake in shares of Global X HealthTech ETF in the fourth quarter valued at approximately $111,000.
Global X HealthTech ETF Price Performance
Shares of HEAL traded up $0.14 during mid-day trading on Friday, hitting $29.32. The stock had a trading volume of 2,593 shares, compared to its average volume of 10,597. The firm has a market cap of $31.08 million, a P/E ratio of 42.80 and a beta of 1.10. The business has a fifty day moving average price of $27.44 and a 200-day moving average price of $26.19. Global X HealthTech ETF has a 52 week low of $23.00 and a 52 week high of $33.59.
About Global X HealthTech ETF
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Featured Stories
- Five stocks we like better than Global X HealthTech ETF
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
